ArticlePharmaceutics2020

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer.

Sho Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.